Literature DB >> 32449738

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells.

Tiao Li1, Chen Long1, Kristen V Fanning1, Chunbin Zou2.   

Abstract

Cigarette smoking is the major etiological cause for lung emphysema and chronic obstructive pulmonary disease (COPD). Cigarette smoking also promotes susceptibility to bacterial infections in the respiratory system. However, the effects of cigarette smoking on bacterial infections in human lung epithelial cells have yet to be thoroughly studied. Described here is a detailed protocol for the preparation of cigarette smoking extracts (CSE), treatment of human lung epithelial cells with CSE, and bacterial infection and infection determination. CSE was prepared with a conventional method. Lung epithelial cells were treated with 4% CSE for 3 h. CSE-treated cells were, then, infected with Pseudomonas at a multiplicity of infection (MOI) of 10. Bacterial loads of the cells were determined by three different methods. The results showed that CSE increased Pseudomonas load in lung epithelial cells. This protocol, therefore, provides a simple and reproducible approach to study the effect of cigarette smoke on bacterial infections in lung epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32449738      PMCID: PMC7946338          DOI: 10.3791/61163

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  37 in total

Review 1.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.

Authors:  Brahmchetna Bedi; Nicholas M Maurice; Vincent T Ciavatta; K Sabrina Lynn; Zhihong Yuan; Samuel A Molina; Myungsoo Joo; William R Tyor; Joanna B Goldberg; Michael Koval; C Michael Hart; Ruxana T Sadikot
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

Review 3.  Managing tobacco use: the neglected cardiovascular disease risk factor.

Authors:  Nancy A Rigotti; Carole Clair
Journal:  Eur Heart J       Date:  2013-09-07       Impact factor: 29.983

4.  Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection.

Authors:  Amit A Lugade; Paul N Bogner; Thomas H Thatcher; Patricia J Sime; Richard P Phipps; Yasmin Thanavala
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

5.  Aberrant epithelial differentiation by cigarette smoke dysregulates respiratory host defence.

Authors:  Gimano D Amatngalim; Jasmijn A Schrumpf; Fernanda Dishchekenian; Tinne C J Mertens; Dennis K Ninaber; Abraham C van der Linden; Charles Pilette; Christian Taube; Pieter S Hiemstra; Anne M van der Does
Journal:  Eur Respir J       Date:  2018-04-26       Impact factor: 16.671

6.  Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study.

Authors:  C Garcia-Vidal; P Almagro; V Romaní; M Rodríguez-Carballeira; E Cuchi; L Canales; D Blasco; J L Heredia; J Garau
Journal:  Eur Respir J       Date:  2009-04-22       Impact factor: 16.671

7.  Cigarette smoke extract modulates Pseudomonas aeruginosa bacterial load via USP25/HDAC11 axis in lung epithelial cells.

Authors:  Chen Long; Yandong Lai; Tiao Li; Toru Nyunoya; Chunbin Zou
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

8.  Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats.

Authors:  Y Chen; M Hanaoka; Y Droma; P Chen; N F Voelkel; K Kubo
Journal:  Eur Respir J       Date:  2009-11-06       Impact factor: 16.671

9.  A novel in vitro model of primary human pediatric lung epithelial cells.

Authors:  Qian Wang; Soumyaroop Bhattacharya; Jared A Mereness; Christopher Anderson; Jacquelyn A Lillis; Ravi S Misra; Stephen Romas; Heidie Huyck; Amanda Howell; Gautam Bandyopadhyay; Kathy Donlon; Jason R Myers; John Ashton; Gloria S Pryhuber; Thomas J Mariani
Journal:  Pediatr Res       Date:  2019-02-18       Impact factor: 3.756

Review 10.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

View more
  1 in total

1.  Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis.

Authors:  Muthanna Sultan; Kiesha Wilson; Osama A Abdulla; Philip Brandon Busbee; Alina Hall; Taylor Carter; Narendra Singh; Saurabh Chatterjee; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.